Combination of interferon-α and ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation

Transplantation Proceedings

Volumn 32, Issue 4, 2000, Pages 714-716

  Ben Ari, Z ^a,b   Tur Kaspa, R ^a,b   Mor, E ^a,b   Shaharabani, E ^a,b   Bar Nathan, N ^a,b   Shapira, Z ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; CYANOCOBALAMIN; ERYTHROPOIETIN; IMMUNOSUPPRESSIVE AGENT; RIBAVIRIN; VIRUS RNA;

ADULT; ANEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG MIXTURE; DRUG SAFETY; FEMALE; HEMOLYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LEUKOPENIA; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; RECURRENT INFECTION; THROMBOCYTOPENIA;

ADULT; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS C; HUMANS; INTERFERON ALFA-2B; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RETROSPECTIVE STUDIES; RIBAVIRIN; TREATMENT OUTCOME;

EID: 0034086371     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(00)00954-4     Document Type: Article

References (9)

1. Feray C, Gigou M, Samuel D, et al: Hepatology 20:1137, 1994
2. Shah G, Demetris AJ, Gavaler JS, et al: Gastroenterology 103:323, 1992
3. Wright TL, Combs C, Kim M, et al: Hepatology 20:773, 1994
4. Gane EJ, Tibbs CJ, Ramage JK, et al: Transplant Int 8:61, 1995
5. Reichard O, Norkrans G, Fryden A, et al: Lancet 351:83, 1998
6. Bizollon TH, Palazzo V, Ducerf CH, et al: Hepatology 26:500, 1997
7. Mazzaferro V, Regalia E, Pulvirenti A, et al: Transplant Proc 29:519, 1997
8. Gotz G, Schon MR, Haefker A, et al: Transplant Proc 30:2104, 1998
9. Houssert B, Conti F, Houssin D, et al: N Engl J Med 330:1161, 1994